Across TCGA pan-cancer cohorts, EFCAB10 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated EFCAB10 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher EFCAB10 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated EFCAB10 expression acts as an unfavorable survival marker.

COAD and ESCA are the cancer types where EFCAB10 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.140	0.871	<.001	39	view →
ESCA	DFS	Median	All	0.177	0.535	.029	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: EFCAB10 tumor-vs-normal RNA expression · all EFCAB10 data types